快速双参数MRI方案检测组织学证实前列腺癌的诊断准确性
这项前瞻性单中心研究纳入129例PSA升高或直肠指检异常的患者,评估快速低成本非增强双参数MRI(bp-MRI)作为二次筛查工具检测临床显著前列腺癌的性能。结果显示bp-MRI检测临床显著癌的敏感性为95.1%,阴性预测值为95.1%,阳性预测值为53.2%,并使10.8%的患者管理发生改变。研究表明快速MRI方案可作为疑似前列腺癌男性的有用二次筛查工具。
要点
- 快速bp-MRI检测临床显著前列腺癌敏感性达95.1%,阴性预测值95.1%。
- bp-MRI使10.8%的患者管理发生改变,假阴性率为4.7%。
- 快速MRI方案可作为疑似前列腺癌男性的二次筛查工具。
核心结论
- 快速双参数MRI检查可检测临床显著病灶,并使10.8%的患者管理发生改变。
- 快速MRI方案可作为疑似前列腺癌男性的有用二次筛查工具。
研究设计与样本
- 前瞻性单中心研究,纳入129例前列腺特异性抗原升高或直肠指检异常的患者。
- 所有患者接受快速双参数MRI方案(高分辨率轴位T2加权和扩散加权成像),随后行标准经直肠超声引导活检,泌尿科医生对MRI结果设盲。
主要发现
- 快速双参数MRI在129例患者中发现176个病灶。
- 快速MRI检测临床显著前列腺癌(Gleason评分3+4及以上)的敏感性为95.1%,阴性预测值为95.1%,阳性预测值为53.2%。
- 快速MRI使10.8%的患者管理发生改变,假阴性率为4.7%。
关键数值与推荐
- 索引病灶根据修改版前列腺影像报告和数据系统(mPI-RADS)2.0版分类。
- 所有mPI-RADS 3、4或5的可疑病灶患者在与泌尿科医生讨论MRI结果后接受认知引导靶向活检。
临床怎么用
- 快速bp-MRI可作为疑似前列腺癌男性的二次筛查工具,用于检测临床显著病灶并指导管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the performance of a rapid, low cost, noncontrast MRI examination as a secondary screening tool in detection of clinically significant prostate cancer. METHODS: In this prospective single institution study, 129 patients with elevated prostate-specific antigen levels or abnormal digital rectal examination findings underwent MRI with an abbreviated biparamatric MRI protocol consisting of high-resolution axial T2- and diffusion-weighted images. Index lesions were classified according to modified Prostate Imaging - Reporting and Data System (mPI-RADS) version 2.0. All patients underwent standard transrectal ultrasound-guided biopsy after MRI with the urologist being blinded to MRI results. Subsequently, all patients with suspicious lesions (mPI-RADS 3, 4, or 5) underwent cognitively guided targeted biopsy after discussion of MRI results with the urologist. Sensitivity and negative predictive value for identification of clinically significant prostate cancer (Gleason score 3+4 and above) were determined. RESULTS: Rapid biparametric MRI discovered 176 lesions identified in 129 patients. Rapid MRI detected clinically significant cancers with a sensitivity of 95.1% with a negative predictive value of 95.1% and positive predictive value of 53.2%, leading to a change in management in 10.8% of the patients. False negative rate of biparametric (bp) MRI was 4.7%. CONCLUSION: We found that a bp-MRI examination can detect clinically significant lesions and changed patient management in 10.8% of the patients. A rapid MRI protocol can be used as a useful secondary screening tool in men presenting with suspicion of prostate cancer.
引用
- Obmann VC, Pahwa S, Tabayayong W, et al. Diagnostic Accuracy of a Rapid Biparametric MRI Protocol for Detection of Histologically Proven Prostate Cancer. Urology. 2018. PMID: 30201301. doi:10.1016/j.urology.2018.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。